BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1 AND Diagnosis
34 results:

  • 1. Clinical significance of decreased or loss of ABO blood group expression in acute myeloid leukaemia: A single-centre retrospective study.
    Han JH; Lee H; Kim JK; Yoo J; Park K; Jekarl DW; Kim Y
    Vox Sang; 2024 Apr; 119(4):353-362. PubMed ID: 38245834
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Too many white cells-TAM, JMML, or something else?
    Satty A; Stieglitz E; Kucine N
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):37-42. PubMed ID: 38066851
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Myeloid Proliferations Associated with Down Syndrome: Clinicopathologic Characteristics of Forty Cases from Five Large Academic Institutions.
    van den Akker TA; Liu YC; Liu H; Chapman J; Levine JM; Weinberg OK; Geyer JT
    Pathobiology; 2024; 91(1):89-98. PubMed ID: 36996802
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. "TAM"ing of the shrew-challenges in the diagnosis of Neonatal leukemia with Down's syndrome -A case report with literature review.
    Manohar S; Jayakumar N
    Indian J Pathol Microbiol; 2022; 65(3):699-701. PubMed ID: 35900507
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A sensitive and inexpensive high-resolution melting-based testing algorithm for diagnosis of transient abnormal myelopoiesis and myeloid leukemia of Down syndrome.
    Camargo R; de Castro Moreira Dos Santos A; Cândido Guido B; Lemos Mendanha Cavalcante L; Silva Dias AC; Mendonça de Pontes R; Magalhães Furtado F; Feitosa Salviano C; Tiziani V; Martins Córdoba JC; Quezado Magalhães IM
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29866. PubMed ID: 35731576
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia-related malignancies.
    Lalonde E; Rentas S; Wertheim G; Cao K; Surrey LF; Lin F; Zhao X; Obstfeld A; Aplenc R; Luo M; Li MM
    Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33832921
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Analysis of Clinical Characteristics and Prognosis in Children with Acute Megakaryoblastic leukemia without Down Syndrome].
    Lin SF; Guo SY; Liu S; Wang J; Huang K; Li Y; Fang JP; Zhou DH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):374-380. PubMed ID: 33812402
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. gata1 mutation analysis and molecular landscape characterization in acute myeloid leukemia with trisomy 21 in pediatric patients.
    Panferova A; Gaskova M; Nikitin E; Baryshev P; Timofeeva N; Kazakova A; Matveev V; Mikhailova E; Popov A; Kalinina I; Hachatrian L; Maschan A; Maschan M; Novichkova G; Olshanskaya Y
    Int J Lab Hematol; 2021 Aug; 43(4):713-723. PubMed ID: 33386779
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Highly sensitive detection of gata1 mutations in patients with myeloid leukemia associated with Down syndrome by combining Sanger and targeted next generation sequencing.
    Terui K; Toki T; Taga T; Iwamoto S; Miyamura T; Hasegawa D; Moritake H; Hama A; Nakashima K; Kanezaki R; Kudo K; Saito AM; Horibe K; Adachi S; Tomizawa D; Ito E
    Genes Chromosomes Cancer; 2020 Mar; 59(3):160-167. PubMed ID: 31606922
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome.
    Falconi G; Fabiani E; Criscuolo M; Fianchi L; Finelli C; Cerqui E; Pelosi E; Screnci M; Gurnari C; Zangrilli I; Postorino M; Laurenti L; Piciocchi A; Testa U; Lo-Coco F; Voso MT
    Leuk Res; 2019 Sep; 84():106191. PubMed ID: 31386932
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Molecular features, prognosis, and novel treatment options for pediatric acute megakaryoblastic leukemia.
    De Marchi F; Araki M; Komatsu N
    Expert Rev Hematol; 2019 May; 12(5):285-293. PubMed ID: 30991862
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Loss of Full-Length gata1 Expression in Megakaryocytes Is a Sensitive and Specific Immunohistochemical Marker for the diagnosis of Myeloid Proliferative Disorder Related to Down Syndrome.
    Lee WY; Weinberg OK; Evans AG; Pinkus GS
    Am J Clin Pathol; 2018 Mar; 149(4):300-309. PubMed ID: 29481579
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Erythroleukemia-historical perspectives and recent advances in diagnosis and management.
    Boddu P; Benton CB; Wang W; Borthakur G; Khoury JD; Pemmaraju N
    Blood Rev; 2018 Mar; 32(2):96-105. PubMed ID: 28965757
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. GATA4 is highly expressed in childhood acute lymphoblastic leukemia, promotes cell proliferation and inhibits apoptosis by activating BCL2 and MDM2.
    Han Q; Xu X; Li J; Wang J; Bai L; Wang A; Wang W; Zhang B
    Mol Med Rep; 2017 Nov; 16(5):6290-6298. PubMed ID: 28849107
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The genetic landscape of paediatric de novo acute myeloid leukaemia as defined by single nucleotide polymorphism array and exon sequencing of 100 candidate genes.
    Olsson L; Zettermark S; Biloglav A; Castor A; Behrendtz M; Forestier E; Paulsson K; Johansson B
    Br J Haematol; 2016 Jul; 174(2):292-301. PubMed ID: 27022003
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Presentation of Acute Megakaryoblastic leukemia Associated with a GATA-1 Mutation Mimicking the Eruption of Transient Myeloproliferative Disorder.
    Boos MD; Wine Lee L; Freedman JL; Novoa RA; Chu EY; Perman MJ
    Pediatr Dermatol; 2015; 32(5):e204-7. PubMed ID: 26205501
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Transient abnormal myelopoiesis in neonates: GATA get the diagnosis.
    Bombery M; Vergilio JA
    Arch Pathol Lab Med; 2014 Oct; 138(10):1302-6. PubMed ID: 25268193
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.
    Thiollier C; Lopez CK; Gerby B; Ignacimouttou C; Poglio S; Duffourd Y; Guégan J; Rivera-Munoz P; Bluteau O; Mabialah V; Diop M; Wen Q; Petit A; Bauchet AL; Reinhardt D; Bornhauser B; Gautheret D; Lecluse Y; Landman-Parker J; Radford I; Vainchenker W; Dastugue N; de Botton S; Dessen P; Bourquin JP; Crispino JD; Ballerini P; Bernard OA; Pflumio F; Mercher T
    J Exp Med; 2012 Oct; 209(11):2017-31. PubMed ID: 23045605
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Distinctive hematological abnormalities in East Asian neonates and children with Down syndrome.
    Kim DW; Kim HR; Shin MG; Baek HJ; Kook H; Hwang TJ; Shin JH; Suh SP; Ryang DW
    Int J Lab Hematol; 2011 Aug; 33(4):369-77. PubMed ID: 21692995
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [gata1 analysis in myeloproliferative disorders associated to trisomy 21].
    Fuster Soler JL; Norton A; Galera Miñarro A; Bermúdez Cortés M; Llinares Riestra ME; Ortuño Giner F
    An Pediatr (Barc); 2011 Jan; 74(1):31-7. PubMed ID: 20870473
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.